Mantle cell lymphoma and autologous stem cell transplantation: no difference in term of outcome regarding the use or not of TBI in the conditioning

被引：0
|
作者：
Peterlin, P. [1 ]
Leux, C. [2 ]
Gastinne, T. [1 ]
Mahe, B. [1 ]
Dubruille, V. [1 ]
Delaunay, J. [1 ]
Chevallier, P. [1 ]
Guillaume, T. [1 ]
Blin, N. [1 ]
Ayari, S. [1 ]
Roland, V. [1 ]
Mohty, M. [1 ]
Milpied, N. [3 ]
Harousseau, J. -L. [4 ]
Moreau, P. [1 ]
Le Gouill, S. [1 ]
机构：
[1] CHU Nantes, F-44035 Nantes 01, France
[2] Regist Canc Loire Atlantique & Vendee, Nantes, France
[3] Hop Haut Leveque, Pessac, France
[4] Ctr Reg Lutte Canc, St Herblain, France
来源：
BONE MARROW TRANSPLANTATION | 2011年 / 46卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S248 / S249
页数：2
相关论文
共 50 条
  • [1] BORTEZOMIB AND BEAM CONDITIONING REGIMEN FOR AUTOLOGOUS STEM CELL TRANSPLANTATION IN MANTLE CELL LYMPHOMA
    Hebraud, B.
    Roussel, M.
    Ysebaert, L.
    Gaudin, C.
    Laurent, G.
    Attal, M.
    Huynh, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 462 - 463
  • [2] Long term outcome of patients with mantle cell lymphoma following autologous stem cell transplantation.
    Jacobsen, ED
    Neuberg, D
    Fisher, DC
    Nadler, LM
    Soiffer, RJ
    Freedman, AS
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 600S - 600S
  • [3] Addition of rituximab to TBI/CY improves the outcome of first-line autologous stem cell transplantation for mantle cell lymphoma
    Seyfarth, B
    Boehme, V
    Stuhlmann, R
    Sonnen, R
    Kneba, M
    Schmitz, N
    Dreger, P
    BONE MARROW TRANSPLANTATION, 2004, 33 : S6 - S6
  • [4] Patterns and Outcome of Relapse After Autologous Stem Cell Transplantation for Mantle Cell Lymphoma
    Dietrich, Sascha
    Tielesch, Blanca
    Rieger, Michael
    Nickelsen, Maike
    Pott, Christiane
    Witzens-Harig, Mathias
    Kneba, Michael
    Schmitz, Norbert
    Ho, Antony D.
    Dreger, Peter
    CANCER, 2011, 117 (09) : 1901 - 1910
  • [5] Characteristics and outcome of relapse after autologous stem cell transplantation for mantle cell lymphoma
    Dietrich, S.
    Tielesch, B.
    Rieger, M.
    Nickelsen, M.
    Pott, C.
    Witzens-Harig, M.
    Kneba, M.
    Schmitz, N.
    Ho, A.
    Dreger, P.
    ONKOLOGIE, 2010, 33 : 133 - 133
  • [6] Characteristics and outcome of relapse after autologous stem cell transplantation for mantle cell lymphoma
    Dietrich, S.
    Tielesch, B.
    Rieger, M.
    Nickelsen, M.
    Pott, C.
    Witzens-Harig, M.
    Kneba, M.
    Ho, A. D.
    Schmitz, N.
    Dreger, P.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S246 - S246
  • [7] Bortezomib and BEAM conditioning regimen for upfront autologous stem cell transplantation in mantle cell lymphoma
    Huynh, A.
    Roussel, M.
    Ysebaert, L.
    Recher, C.
    Huguet, F.
    Nouvel, C.
    Laurent, G.
    Attal, M.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S242 - S242
  • [8] Autologous stem cell transplantation and rituximab for mantle cell lymphoma
    Capote, F.
    Gonzalez-Barca, E.
    Bergua, J.
    Calvo, J. Fernandez
    Oriol, A.
    Garcia-Boyero, R.
    Ramirez, M.
    Caballero, D.
    Romero, A.
    Perez, E.
    Queizan, J.
    Pascual, M.
    Cantalapiedra, A.
    Giraldo, P.
    Palomera, L.
    Guinot, M.
    Ribera, J.
    Leon, A.
    Gil, J.
    Fernandez-Sevilla, A.
    ANNALS OF ONCOLOGY, 2008, 19 : 174 - 174
  • [9] Autologous stem cell transplantation in patients with mantle cell lymphoma
    Oinonen, R
    Jantunen, E
    Itälä, M
    Lehtinen, T
    Kuittinen, O
    Franssila, K
    Wiklund, T
    Elonen, E
    LEUKEMIA & LYMPHOMA, 2002, 43 (06) : 1229 - 1237
  • [10] AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) FOR MANTLE CELL LYMPHOMA
    Mabindra, A.
    Copelan, E.
    Bolwell, B.
    Rybicki, L.
    Dean, R.
    Kalaycio, M.
    Sobecks, R.
    Ferraro, C.
    Cherni, K.
    Pohlman, B.
    Sweetenham, J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 64 - 65
12345